US legislative update: takeaways for European pharma : compa

Keith A Zullow and Jenny J Zhang examine upcoming US pharmaceutical regulation and how, if passed, it could impact European pharma/biopharma.

Related Keywords

New York , United States , Jennyj Zhang , Keitha Zullow , Supreme Court , Human Services , Drug Administration , Us Congress , Us Federal Trade Commission , Goodwin Procter , Inflation Reduction Act , Citizen Petition , Citizen Petitions , Senate Bill , Ensuring Timely Access , Generics Act , Trade Commission , Representatives Bill , Stop Stalling Access , Affordable Medications , Affordable Prescriptions , Patients Through Improvements , Patent Litigation Act , Biologics Price Competition , Innovation Act , Preserve Access , Affordable Generics , Biosimilars Act , Generic Substitution Noninterference Act , Star Rating , Medicare Advantage , Congressional Session , Time Wasting Abuse Limiting Legitimate Innovation , New Generics , Patients Act , Patients Through Promoting Competition Act , Patent Litigation , Continued Cures Act , Continued Cures , Patent Attorney , Intellectual Property Litigation ,